Newsletter Signup | Join Community | Cancer Types
Ask The Experts About Multiple Myeloma
Xpovio treatment of Multiple Myeloma receives FDA approval - combination appears superior to Vd with less neuropathy.
Talquetamab is a CPRC5DxCD3 Bispecific Antibody being developed for the treatment of myeloma - early results promising.
Pfizer PF-06863135, an investigational B-cell maturation antigen (BCMA) CD3-targeted bispecific antibody.
BCMAxCD3 Bispecific Teclistamab show preliminary effectiveness in patients with advanced Multiple Myeloma
Clinical results for REGN 5458 Bispecific Antibody appear promising for treatment of advanced myeloma-2020 ASH Update
ASH 2020 update on CAR-T therapy in multiple myeloma and other targeted therapies. CAR T continues to look promising.
Cancer Connect - Treatment of Recurrent Multiple Myeloma
Treatment of stage II-III myeloma may include chemotherapy, precision medicines, stem cell transplant & supportive care.
Has anyone elected to receive triple drug therapy and delay their ASCT? Seems like there is…
New Antibody that targets CD74 on myeloma cells gets nod from FDA to proceed.…
UK doctors identify a new target for treating Multiple Myeloma: http://www.imperial.ac…